Lercanidipine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Lercanidipine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 27: Line 27:
{{CMG}}
{{CMG}}


{{Editor Join}}
 





Revision as of 16:51, 9 August 2012

Lercanidipine
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC36H41N3O6
Molar mass611.727 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]




Overview

Lercanidipine is a calcium channel blocker of the dihydropyridine class.

It is sold under various commercial names including Zanidip.

Further reading

  • Lin T, Voon W, Yen H, Huang C, Su H, Lai W, Sheu S (2006). "Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters". Kaohsiung J Med Sci. 22 (4): 177–83. PMID 16679299.
  • Martinez M, Lopes L, Coelho E, Nobre F, Rocha J, Gerlach R, Tanus-Santos J (2006). "Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension". J Cardiovasc Pharmacol. 47 (1): 117–22. PMID 16424795.
  • Agrawal R, Marx A, Haller H (2006). "Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension". J Hypertens. 24 (1): 185–92. PMID 16331117.

External links

Template:Calcium channel blockers

de:Lercanidipin


Template:WikiDoc Sources